Decoy Therapeutics (DCOY) on Friday filed a statement to register the resale of up to 3.77 million shares of common stock issuable upon the exercise of warrants issued in a private placement that closed on June 29.
The company said it is not selling any shares under the registration statement and will not receive proceeds from sales by the selling stockholders, though it may receive proceeds from any cash exercise of the warrants.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments